X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
parkinson's disease (67) 67
humans (62) 62
index medicus (58) 58
male (57) 57
clinical neurology (55) 55
female (53) 53
middle aged (51) 51
aged (42) 42
neurosciences (40) 40
neurology (33) 33
deep brain stimulation (27) 27
parkinson disease - therapy (23) 23
movement disorders (20) 20
parkinson disease - drug therapy (18) 18
parkinson’s disease (17) 17
subthalamic nucleus (17) 17
treatment outcome (17) 17
parkinson disease - physiopathology (16) 16
medical research (15) 15
medicine, experimental (15) 15
neuropsychological tests (15) 15
parkinson disease - complications (15) 15
levodopa (14) 14
neurodegenerative diseases (14) 14
deep brain stimulation - methods (13) 13
dopa (13) 13
parkinson disease - psychology (13) 13
parkinsons disease (13) 13
adult (12) 12
medicine & public health (12) 12
care and treatment (11) 11
dyskinesias (11) 11
parkinson disease (11) 11
deep brain stimulation - adverse effects (10) 10
deep brain-stimulation (10) 10
dementia (10) 10
follow-up studies (10) 10
neuroradiology (10) 10
severity of illness index (10) 10
activities of daily living (9) 9
parkinsons-disease (9) 9
patients (9) 9
analysis (8) 8
antiparkinson agents - therapeutic use (8) 8
carbidopa (8) 8
drug combinations (8) 8
neurosurgery (8) 8
nucleus stimulation (8) 8
parkinson disease - diagnosis (8) 8
prevalence (8) 8
risk factors (8) 8
sleep (8) 8
subthalamic nucleus - physiopathology (8) 8
surgery (8) 8
dopamine (7) 7
levodopa - therapeutic use (7) 7
parkinson disease - epidemiology (7) 7
prospective studies (7) 7
psychiatry (7) 7
research (7) 7
subthalamic nucleus - physiology (7) 7
brain stimulation (6) 6
cognition (6) 6
cohort studies (6) 6
gait (6) 6
levodopa - administration & dosage (6) 6
levodopa - adverse effects (6) 6
mood (6) 6
motor (6) 6
retrospective studies (6) 6
scale (6) 6
surveys and questionnaires (6) 6
time factors (6) 6
5-year follow-up (5) 5
aged, 80 and over (5) 5
antiparkinson agents - administration & dosage (5) 5
anxiety (5) 5
case-control studies (5) 5
cognitive ability (5) 5
complications and side effects (5) 5
diagnosis (5) 5
disability evaluation (5) 5
disease (5) 5
follow-up (5) 5
further section (5) 5
health aspects (5) 5
management (5) 5
neurons (5) 5
neuropathy (5) 5
neuroscience (5) 5
peripheral neuropathy (5) 5
psychology (5) 5
quality of life (5) 5
self-awareness (5) 5
subthalamic nucleus - surgery (5) 5
age (4) 4
autonomic neuropathy (4) 4
basal ganglia (4) 4
blood pressure (4) 4
carbidopa - administration & dosage (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Movement Disorders, ISSN 0885-3185, 09/2013, Volume 28, Issue 10, pp. 1391 - 1397
Journal Article
Journal Article
Neurological Sciences, ISSN 1590-1874, 06/2019, pp. 1 - 8
ObjectivesCommunication processes play a key role in the patient-doctor relationship. Few studies have considered communicative processes in advanced... 
Parkinson's disease | Neurodegenerative diseases | Deep brain stimulation | Patients | Movement disorders | Communication
Journal Article
Neurological Sciences, ISSN 1590-1874, 7/2018, Volume 39, Issue 7, pp. 1303 - 1304
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s10072-018-3296-3 
Neurology | Neurosurgery | Medicine & Public Health | Psychiatry | Neuroradiology | TREMOR | NEUROSCIENCES | CLINICAL NEUROLOGY | PARKINSONS-DISEASE | Adult | Male | Klinefelter Syndrome - complications | Humans | Movement Disorders - etiology | Neurosciences | Movement disorders
Journal Article
Acta Neurologica Scandinavica, ISSN 0001-6314, 08/2019, Volume 140, Issue 2, pp. 157 - 161
Background Few studies have suggested that levodopa‐carbidopa intestinal gel (LCIG) may have a benefit on Parkinson's disease (PD) axial signs. Aims of the... 
axial signs | gait | levodopa‐carbidopa intestinal gel | Parkinson’s disease | Dihydroxyphenylalanine | Parkinson's disease | Gait | Neurodegenerative diseases | Intestine | Levodopa | Movement disorders
Journal Article
Journal of Neurology, ISSN 0340-5354, 1/2017, Volume 264, Issue 1, pp. 40 - 48
Journal Article
Journal Article
Journal of Neurology, ISSN 0340-5354, 1/2019, Volume 266, Issue 1, pp. 85 - 91
Falls represent one of the main complications of Parkinson’s disease (PD), significantly lowering quality of life. Cardiovascular autonomic neuropathy (cAN) is... 
Falls | Neurology | Neurosciences | Medicine & Public Health | RBD | Parkinson disease | Autonomic neuropathy | Neuroradiology | Orthostatic hypotension | MANAGEMENT | SUBTYPES | DYSAUTONOMIA | SYMPTOMS | SYNUCLEINOPATHIES | CLINICAL NEUROLOGY | IMPACT | HEALTH | Prevalence | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Male | Parkinson Disease - drug therapy | Autonomic Nervous System Diseases - diagnosis | Autonomic Nervous System Diseases - psychology | Cognitive Dysfunction - epidemiology | Aged, 80 and over | Cardiovascular Diseases - epidemiology | Parkinson Disease - epidemiology | Female | Accidental Falls | Cardiovascular Diseases - diagnosis | Autonomic Nervous System Diseases - epidemiology | Risk Factors | Gait Disorders, Neurologic - psychology | Parkinson Disease - psychology | Gait Disorders, Neurologic - diagnosis | Gait Disorders, Neurologic - epidemiology | Parkinson Disease - diagnosis | Gait Disorders, Neurologic - drug therapy | Aged | Cardiovascular Diseases - psychology | Complications and side effects | Parkinson's disease | Analysis | Autonomic neuropathies | Falls (Accidents) | Health aspects | Risk factors | Quality of life | Dopamine | Gait | Neurodegenerative diseases | Cognitive ability | Sleep (REM) | Neuropathy | Patients | Hypotension | Autonomic nervous system | Health risk assessment | Movement disorders | Dopamine receptors | Dyskinesia
Journal Article
Frontiers in Neurology, ISSN 1664-2295, 2019, Volume 10, Issue MAY, p. 577
Pisa syndrome (PS) is a lateral flexion of the trunk frequently associated with Parkinson's disease (PD). The pathophysiology of PS remains unclear, but the... 
Cognition | Parkinson's disease | Neuropsychology | Pisa syndrome | Self-perception | Medicine, Experimental | Medical research | Risk factors | neuropsychology | self-perception | cognition
Journal Article
Journal of Neurology, Neurosurgery and Psychiatry, ISSN 0022-3050, 03/2018, Volume 89, Issue 3, pp. 305 - 310
Journal Article
Journal of Neurology, ISSN 0340-5354, 5/2019, Volume 266, Issue 5, pp. 1141 - 1152
We sought to analyze the blood pressure (BP) circadian rhythm in Parkinson’s disease (PD), multiple system atrophy (MSA), and pure autonomic failure (PAF) and... 
Neurology | Neurosciences | Medicine & Public Health | Cardiovascular autonomic neuropathy | Reverse dipping | Blood pressure variability | Neuroradiology | Orthostatic hypotension | Ambulatory blood pressure monitoring | DIAGNOSIS | MANAGEMENT | GUIDELINES | CLINICAL NEUROLOGY | MULTIPLE SYSTEM ATROPHY | PURE AUTONOMIC FAILURE | WHITE-MATTER HYPERINTENSITIES | DYSFUNCTION | HYPERTENSION | PARKINSONS-DISEASE | Humans | Middle Aged | Male | Parkinson Disease - drug therapy | Dopamine Agents - therapeutic use | Pure Autonomic Failure - physiopathology | Heart Rate - drug effects | Statistics, Nonparametric | Aged, 80 and over | Heart Rate - physiology | Female | Blood Pressure - drug effects | Blood Pressure - physiology | Retrospective Studies | Vasoconstrictor Agents - therapeutic use | Circadian Rhythm - physiology | Antihypertensive Agents - therapeutic use | Parkinson Disease - physiopathology | Valsalva Maneuver | Monitoring, Ambulatory | Multiple System Atrophy - drug therapy | Aged | Pure Autonomic Failure - drug therapy | Multiple System Atrophy - physiopathology | Circadian Rhythm - drug effects | Circadian rhythms | Dopamine | Parkinson's disease | Activities of daily living | Daytime | Neurodegenerative diseases | Platelet-activating factor | Data processing | Circadian rhythm | Nighttime | Patients | Hypotension | Atrophy | Autonomic nervous system | Vasoactive agents | Blood pressure | Diagnosis | Movement disorders | Dopamine receptors
Journal Article